IP Library Assignment 030763/0308
Patent Assignment
Reel/Frame 030763/0308

Assignment of Assignor's Interest

Recorded: 2013-07-09 Pages: 8
Assignor
ABBOTT GMBH & CO KG
Executed: 2012-11-01
Assignee
ABBVIE DEUTSCHLAND GMBH & CO KG
MAX-PLANCK-RING 2A, WIESBADEN, 65205, GERMANY
Covered Properties (62)
Stable Emulsion Suitable for Pharmaceutical Administration, the Production Thereof and Emulsion for Pharmaceutical Use
Patent: 5,496,818 →
Application: 08/057,553 →
Resolution of Racemic Verapamil
Patent: 5,457,224 →
Application: 08/244,681 →
Preparation of Colloidal Aqueous Solutions of Active Substances of Low Solubility and a Lipid Therefor
Patent: 5,720,973 →
Application: 08/492,006 →
The Preparation of Colloidal Aqueous Solutions of Active Substances of Low Solubility
Patent: 5,626,864 →
Application: 08/495,597 →
Multiphase Active Ingredient-Containing Formulations
Patent: 6,787,157 →
Application: 09/037,792 →
Method for Establishing a Dosage Plan for Thrombin Inhibitors
Patent: 6,489,289 →
Application: 09/190,185 →
Publication: US 2001/0006620
Endothelin Antagonist and Beta Receptor Blocking Agent as Combined Preparations
Patent: 6,352,992 →
Application: 09/508,989 →
Endothelin Antagonist and a Renin-Angiotensin System Inhibitor as a Combined Preparation
Patent: 6,329,384 →
Application: 09/508,993 →
Method for Combating Obesity
Patent: 6,197,780 →
Application: 09/530,131 →
Method for Producing Solvent-Free Non-Crystalline Biologically Active Substances
Patent: 6,547,997 →
Application: 09/554,215 →
Multipart Label for Blister Packs, and the Production and Use Thereof
Patent: 6,669,236 →
Application: 09/688,830 →
Exactly Divisible Tablet
Patent: 6,692,765 →
Application: 09/762,399 →
Method for Producing Solid Dosing Forms
Patent: 6,669,879 →
Application: 09/763,662 →
Method and device for producing tablets
Application: 09/787,079 →
Use of Anticoagulant Agents in the Extracorporeal Treatment of Blood
Patent: 6,809,076 →
Application: 09/811,410 →
Publication: US 2002/0039994
Method of Producing Solid Dosage Forms
Patent: 6,737,005 →
Application: 09/831,397 →
Cleavable Solid Dosage Forms and Method for the Production Thereof
Patent: 6,488,939 →
Application: 09/857,018 →
Method and Device for Producing Different Solid Dosage Forms
Patent: 6,669,883 →
Application: 09/869,666 →
Quick-Release Extrudates, Method for Preparing the Same and Compositions Obtained from Said Extrudates
Patent: 6,569,455 →
Application: 10/031,129 →
Dibenzodiazepine Derivatives, Their Preparation and Use
Patent: 7,026,311 →
Application: 10/041,556 →
Publication: US 2003/0139394
Method for Producing Solid Shape Forms Containing an Active Ingredient
Patent: 7,014,810 →
Application: 10/149,762 →
Publication: US 2003/0015814
Formulations of Active Components in the Form of a Solid Dispersion
Patent: 8,021,688 →
Application: 10/169,665 →
Publication: US 2003/0109639
Substituted Indoles Which Are Parp Inhibitors
Patent: 7,087,637 →
Application: 10/275,574 →
Publication: US 2004/0067949
Self-Emulsifying Active Substance Formulation and Use of This Formulation
Patent: 8,470,347 →
Application: 10/296,451 →
Publication: US 2004/0013697
Integrin Ligands
Patent: 7,279,468 →
Application: 10/311,369 →
Publication: US 2004/0063934
Test System for Evaluating the Compatibility of Biologically Active Substances with Copolymers
Patent: 8,293,374 →
Application: 10/508,483 →
Publication: US 2005/0131054
Method for Producing Solid Galenic Formulations Using a Crosslinked Non-Thermoplastic Carrier
Patent: 7,846,477 →
Application: 10/530,483 →
Publication: US 2006/0257470
3-Substituted 3,4-Dihydro-Thieno[2,3-D]Pyrimidin-4-One Derivatives, Production and Use Thereof
Patent: 7,491,729 →
Application: 10/539,708 →
Publication: US 2006/0142317
Amyloid Beta(1-42) Oligomers, Derivatives Thereof and Antibodies Thereto, Methods of Preparation Thereof and Use Thereof
Patent: 7,902,328 →
Application: 10/543,841 →
Publication: US 2007/0098721
Triazole Compounds and the Therapeutic Use Thereof
Patent: 7,465,744 →
Application: 10/544,550 →
Publication: US 2006/0241137
Pyrimidin-2-One Compounds and Their Use as Dopamine D3 Receptor Ligands
Patent: 8,008,488 →
Application: 10/548,931 →
Publication: US 2006/0235004
Keto Lactam Compounds and Use Thereof
Patent: 7,723,384 →
Application: 10/582,285 →
Publication: US 2007/0219182
N-[(Piperazinyl)Hetaryl]Arylsulfonamide Compounds
Patent: 7,320,979 →
Application: 10/823,317 →
Publication: US 2006/0160809
Triazole Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Patent: 6,919,342 →
Application: 10/860,823 →
Publication: US 2004/0259882
Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment
Application: 11/597,799 →
Publication: US 2008/0107733
Method for the treatment of amyloidoses
Patent: 8,895,004 →
Application: 12/529,467 →
Publication: US 2011/0130549
Pharmaceutical Dosage Form for Oral Administration of a Bcl 2 Family Inhibitor
Patent: 9,642,796 →
Application: 12/796,000 →
Publication: US 2010/0310648
Use of Substituted Oxindole Derivatives for the Treatment and Prophylaxis of Pain
Application: 12/797,385 →
Publication: US 2011/0059983
Modulators of 5-Ht Receptors and Methods of Use Thereof
Patent: 8,846,951 →
Application: 12/950,029 →
Publication: US 2011/0118231
Methods of Treating Retinal Nerve Fiber Layer Degeneration with Monoclonal Antibodies Against a Retinal Guidance Molecule (Rgm) Protein
Patent: 9,175,075 →
Application: 12/963,461 →
Publication: US 2011/0135664
Carboxamide Compounds and Their Use as Calpain Inhibitors V
Patent: 9,051,304 →
Application: 12/972,663 →
Publication: US 2011/0152265
Carboxamide Compounds and Their Use as Calpain Inhibitors Iv
Patent: 8,598,211 →
Application: 12/972,679 →
Publication: US 2011/0152325
Method and Device for Determining Mechanical Stress Load and Interface Effects on Particles Dispersed in a Fluid
Patent: 8,607,639 →
Application: 13/049,362 →
Publication: US 2012/0031191
Novel Small Molecule Potentiators of Metabotropic Glutamate Receptors I
Patent: 8,664,214 →
Application: 13/071,753 →
Publication: US 2011/0245232
Novel Small Molecule Potentiators of Metabotropic Glutamate Receptors
Patent: 8,314,120 →
Application: 13/073,087 →
Publication: US 2011/0245247
Amyloid-Beta Binding Proteins
Patent: 8,987,419 →
Application: 13/085,891 →
Publication: US 2011/0256138
N-[Piperazinyl Hetaryl]Arylsufonamide Compounds with Affinity for the Dopamine D3 Receptor
Patent: 8,476,275 →
Application: 13/117,269 →
Publication: US 2011/0294817
Amyloid Beta(1-42) Oligomers, Derivatives Thereof and Antibodies Thereto, Methods of Preparation Thereof and Use Thereof
Patent: 9,176,150 →
Application: 13/195,533 →
Publication: US 2012/0034166
Phenalkylamine Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 9,045,459 →
Application: 13/206,750 →
Publication: US 2012/0088790
Phenalkylamine Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 8,877,794 →
Application: 13/206,937 →
Publication: US 2012/0077796
Aminoindane Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 8,846,743 →
Application: 13/207,030 →
Publication: US 2012/0040948
Tetraline and Indane Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 8,883,839 →
Application: 13/207,160 →
Publication: US 2012/0040947
Heterocyclic Compounds and Their Use as Glycogen Synthase Kinase-3 Inhibitors
Patent: 9,266,855 →
Application: 13/245,123 →
Publication: US 2012/0077840
Low-Molecular Serine Proteases Inhibitors Comprising Polyhydroxy-Alkyl and Polyhydroxy-Cycloalkyl Radicals
Application: 13/277,829 →
Publication: US 2012/0190832
Heterocyclic Compounds and Their Use as Glycogen Synthase Kinase-3 Inhibitors
Patent: 9,090,592 →
Application: 13/339,884 →
Publication: US 2012/0172376
Self-Emulsifying Active Ingredient Formulation and the Use of This Formulation
Application: 13/449,971 →
Publication: US 2012/0225953
Method for Evaluating the Solubility of a Crystalline Substance in a Polymer
Application: 13/522,654 →
Tetraline and Indane Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 9,051,280 →
Application: 13/546,434 →
Publication: US 2012/0295881
Test Solvent for Evaluating the Compatibility of Biologically Active Substances and Graft Copolymers
Patent: 9,594,073 →
Application: 13/578,659 →
Publication: US 2013/0118238
Tablet
Patent: 626,214 →
Application: 29/301,994 →
Tablet
Patent: 641,863 →
Application: 29/375,432 →
Tablet
Patent: 641,864 →
Application: 29/375,447 →
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 7, 2001
From: ROSENBERG, JOERG; LUDWIG, KARL; MAIER, WERNER; TRAPP, BURKHARD
To: KNOLL AKTIENGESELLSCHAFT
Reel/Frame 012056/0918 →
Assignment of Assignor's Interest Jul 2, 2001
From: ROSENBERG, JOERG; MAIER, WERNER
To: KNOLL AKTIENGESELLSCHAFT
Reel/Frame 012050/0624 →
Corrective Assignment to Correct the Assignee Address. Document Previously Recorded on Reel 013758 Frame 0551, Assignor Confirms the Assignment of the Entire Interest. Sep 9, 2003
From: KNOLL AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 014455/0058 →
Change of Name Sep 9, 2003
From: KNOLL AKTIENGESSELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 014446/0831 →
Assignment of Assignor's Interest Oct 8, 2003
From: GRANDEL, ROLAND; LUBISCH, WILFRIED; KOCK, MICHAEL; HOGER, THOMAS
To: BASF AG
Reel/Frame 014561/0869 →
Assignment of Assignor's Interest Oct 24, 2003
From: LUBISCH, WILFRIED; GRANDEL, ROLAND; BRAJE, WILFRIED; SUBKOWSKI, THOMAS
To: ABBOTT GMBH & CO. KG
Reel/Frame 014620/0035 →
Corrective Document Reel 014561 Frame 0869 Jun 14, 2004
From: GRANDEL, ROLAND; LUBISCH, WILFRIED; KOCK, MICHAEL; HOGER, THOMAS
To: BASF AG
Reel/Frame 015448/0489 →
Assignment of Assignor's Interest Jul 28, 2005
From: BAYER AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 016814/0347 →
Release of Security Interest Jan 18, 2006
From: GATX VENTURES, INC. AND SILICON VALLEY BANK
To: MYOGEN, INC.
Reel/Frame 017025/0877 →
Release of Security Interest Jan 23, 2006
From: SILICON VALLEY BANK
To: MYOGEN, INC.
Reel/Frame 017480/0281 →
Assignment of Assignor's Interest Sep 14, 2006
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 018279/0869 →
Merger Jan 31, 2011
From: ABBOTT GMBH
To: ABBOTT GMBH & CO. KG
Reel/Frame 025723/0685 →
Change of Name Sep 5, 2012
From: KNOLL AKTIENGESELLSCHAFT
To: KNOLL GMBH
Reel/Frame 028914/0684 →
Change of Name Sep 5, 2012
From: ABBOTT GMBH
To: ABBOTT GMBH & CO. KG
Reel/Frame 028914/0918 →
Merger Sep 5, 2012
From: KNOLL GMBH
To: ABBOTT GMBH
Reel/Frame 028914/0843 →